GeneQuantum
Suzhou, China· Est.
GeneQuantum focuses on creating next-generation antibody-drug conjugates (ADCs) with proprietary linker-payload technologies for oncology.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
GeneQuantum focuses on creating next-generation antibody-drug conjugates (ADCs) with proprietary linker-payload technologies for oncology.
OncologyAntibodiesDrug Delivery